EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Dual-Action Theranostic Nanoparticles Delivering Toll-Like Receptor 2 Inhibitors and Chemotherapy Target Breast Cancer Cells and the Tumor Microenvironment

Antonino Di Lorenzo, Chiara Romiti, Alessandro Amaolo iD, Chiara Cossu, Antonella Iacoviello iD, Claudia Curcio, Marco Forni, Cristina Zanini, Federica Cavallo, Giuseppe Ferrauto, Enza Di Gregorio iD, Laura Conti iD

International Journal of Nanomedicine · 2026-02 · Volume 21 · 1-23

DOI: 10.2147/ijn.s556284 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Nanomedicine, 2026-02. Verfasst von Antonino Di Lorenzo und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biotechnology and Health Sciences, University of Turin, Turin, Italy. Hauptthemen laut MEDLINE: Toll-Like Receptor 2, Breast Neoplasms, Antineoplastic Agents, Nanoparticles. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Toll-Like Receptor 2Breast NeoplasmsAntineoplastic AgentsNanoparticlesNanoparticle Drug Delivery SystemAnimalsTumor MicroenvironmentFemaleDoxorubicinCell Line, TumorPolylactic Acid-Polyglycolic Acid CopolymerMiceHumansPolyglycolic AcidTheranostic NanomedicineLactic AcidLiposomesMice, Inbred BALB CCell SurvivalApoptosis

Stichwörter der Autor:innen

TLR2 inhibitorbreast cancerhybrid PLGA-lipid NPsimmunotherapyliposomesmagnetic resonance imaging

Substanzen

Toll-Like Receptor 2DoxorubicinPolylactic Acid-Polyglycolic Acid CopolymerPolyglycolic AcidAntineoplastic AgentsLactic AcidLiposomesNanoparticle Drug Delivery System

Autor:innen und Institutionen

  • Department of Molecular Biotechnology and Health Sciences, University of Turin, Turin, Italy.
  • Molecular Biotechnology Center "Guido Tarone", University of Turin, Turin, Italy.
  • Department of Medical Biotechnologies, University of Siena, Siena, Italy.

ORCID-Profile: Alessandro Amaolo, Antonella Iacoviello, Enza Di Gregorio, Laura Conti

Zitieren

APA

Di Lorenzo, A., Romiti, C., Amaolo, A., Cossu, C., Iacoviello, A., Curcio, C., Forni, M., Zanini, C., Cavallo, F., Ferrauto, G., Di Gregorio, E., & Conti, L. (2026). Dual-Action Theranostic Nanoparticles Delivering Toll-Like Receptor 2 Inhibitors and Chemotherapy Target Breast Cancer Cells and the Tumor Microenvironment. International Journal of Nanomedicine, Volume 21, 1-23. https://doi.org/10.2147/ijn.s556284

Vancouver

Di Lorenzo A, Romiti C, Amaolo A, Cossu C, Iacoviello A, Curcio C, et al. Dual-Action Theranostic Nanoparticles Delivering Toll-Like Receptor 2 Inhibitors and Chemotherapy Target Breast Cancer Cells and the Tumor Microenvironment. International Journal of Nanomedicine. 2026;Volume 21:1-23. doi:10.2147/ijn.s556284

BibTeX
@article{DiLorenzo2026,
  author = {Di Lorenzo, Antonino and Romiti, Chiara and Amaolo, Alessandro and Cossu, Chiara and Iacoviello, Antonella and Curcio, Claudia and Forni, Marco and Zanini, Cristina and Cavallo, Federica and Ferrauto, Giuseppe and Di Gregorio, Enza and Conti, Laura},
  title = {Dual-Action Theranostic Nanoparticles Delivering Toll-Like Receptor 2 Inhibitors and Chemotherapy Target Breast Cancer Cells and the Tumor Microenvironment},
  journal = {International Journal of Nanomedicine},
  year = {2026},
  volume = {Volume 21},
  pages = {1--23},
  doi = {10.2147/ijn.s556284}
}
Kostenlos starten →